The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
VAX014 for instillation in subjects with nonmuscle-invasive bladder cancer.
 
Seth P. Lerner
Stock and Other Ownership Interests - C2i genomics
Honoraria - Annenberg Center for Health Sciences at Eisenhower (ACHS); Clinical Care Options; Grand Rounds in Urology; Ology Medical Education; UroToday
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; C2i Genomics; FerGene; Ferring; Merck Sharp & Dohme; Pfizer/EMD Serono; Roche/Genentech; Urogen pharma; Vaxiion; Verity Pharmaceuticals
Research Funding - Endo Pharmaceuticals; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; Urogen pharma; Vaxiion; Viventia Biotech
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Other Relationship - Bladder Cancer Journal; UpToDate
 
Lawrence Ivan Karsh
Stock and Other Ownership Interests - Swan Valley Medical
Honoraria - Astellas Pharma; Bayer; Dendreon; Janssen; Pfizer
Consulting or Advisory Role - 3D Biopsy; Astellas Oncology; AstraZeneca; Bayer; Dendreon; Ferring; Janssen; Pfizer; Vaxiion
Speakers' Bureau - Astellas Oncology; Bayer; Clovis Oncology; Janssen; Pfizer
Research Funding - Astellas Oncology (Inst); AstraZeneca (Inst); Bayer (Inst); BioXcel Therapeutics (Inst); Bristol-Myers Squibb (Inst); CU Optics (Inst); CUSP (Inst); Dendreon (Inst); Epizyme (Inst); Exact Sciences (Inst); Ferring (Inst); FKD Therapies (Inst); Genentech/Roche (Inst); GenomeDx (Inst); Genomic Health (Inst); Janssen (Inst); Merck (Inst); Myovant Sciences (Inst); Nucleix (Inst); OncoCellMDx (Inst); Pfizer (Inst); PharmTech (Inst); Precision Medicines (Inst); QED Therapeutics (Inst); Siemens (Inst); UROGENE (Inst); Vaxiion (Inst)
Travel, Accommodations, Expenses - Astellas Oncology; Bayer; Dendreon; Janssen; Pfizer
 
Michael A. O'Donnell
Consulting or Advisory Role - Abbott Laboratories; Fidia Pharma USA; Merck; Photocure; Theralase; UroGen pharma; Vaxiion
Research Funding - Abbott Laboratories (Inst); Photocure (Inst)
Travel, Accommodations, Expenses - Photocure
 
Neal D. Shore
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Sanofi; CG Oncology; CG Oncology; Clovis Oncology; Dendreon; Exact Imaging; Exact Sciences; FerGene; Ferring; Foundation Medicine; Genesis Cancer Care; Genzyme; Genzyme; InVitae; Janssen Scientific Affairs; MDxHealth; Medivation/Astellas; Merck; Myovant Sciences; Myriad Genetics; Nymox; Pacific Edge Biotechnology; Peerview; Pfizer; Phosphorus; Propella Therapeutics; Sanofi; Sesen Bio; Speciality Networks; Tolmar; Urogen pharma
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Clovis Oncology; Dendreon; Foundation Medicine; Guardant Health; Janssen; Merck; Pfizer
Research Funding - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Boston Scientific; Bristol-Myers Squibb/Pfizer; Clovis Oncology; Dendreon; Exact Imaging; Ferring; Foundation Medicine; InVitae; Janssen; MDxHealth; Merck; Myovant Sciences; Myriad Genetics; Nymox; Pfizer; Sanofi; Sesen Bio; Tolmar
 
Yair Lotan
Stock and Other Ownership Interests - CAPs medical; Vessi Medical
Consulting or Advisory Role - Abbvie; AstraZeneca; BMS; C2i genomics; Cleveland Diagnostics; Fergene; Fergene; Merck; Nanorobotics; Nucleix; pacific edge; Photocure; Urogen pharma; Vessi Medical
Research Funding - Abbott Molecular (Inst); Augmenix; BioCancell (Inst); Cepheid; Cepheid (Inst); GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst); Photocure (Inst); storz (Inst)
 
Shingo Tsuji
Employment - Vaxiion Therapeutics
Stock and Other Ownership Interests - Vaxiion Therapeutics
Patents, Royalties, Other Intellectual Property - Vaxiion Therapeutics
 
Matthew Giacalone
Employment - Vaxiion Therapeutics
Leadership - Vaxiion Therapeutics
Stock and Other Ownership Interests - Vaxiion Therapeutics
Patents, Royalties, Other Intellectual Property - Patent holder for Vaxiion Therapeutics